{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:55:48Z","timestamp":1790225748625,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jneuroim.2017.01.024","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T12:00:49Z","timestamp":1486209649000},"page":"102-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Soluble CD40 ligand contributes to blood\u2013brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"305","author":[{"given":"Hiroki","family":"Masuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyuki","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jneuroim.2017.01.024_bb0005","doi-asserted-by":"crossref","first-page":"22342","DOI":"10.3390\/ijms151222342","article-title":"The signaling role of CD40 ligand in platelet biology and in platelet component transfusion","volume":"15","author":"Aloui","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.jneuroim.2017.01.024_bb0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.0000028962.04520.01","article-title":"Platelet-derived CD40L: the switch-hitting player of cardiovascular disease","volume":"106","author":"Andr\u00e9","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jneuroim.2017.01.024_bb0015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/cei.12733","article-title":"Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase","volume":"183","author":"Barros","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2017.01.024_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2014.10.005","article-title":"The cerebrospinal fluid cytokine signature of multiple sclerosis: a homogenous response that does not conform to the Th1\/Th2\/Th17 convention","volume":"277","author":"Burman","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.jneuroim.2017.01.024_bb0025","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.jneuroim.2017.01.024_bb0030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10067-006-0389-9","article-title":"The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value","volume":"26","author":"Cifersk\u00e1","year":"2007","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.01.024_bb0035","article-title":"Finding NMO","volume":"4","author":"Daneman","year":"2016","journal-title":"Neurol. Neurophysiol. Neurosci."},{"issue":"12","key":"10.1016\/j.jneuroim.2017.01.024_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051793","article-title":"Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders","volume":"7","author":"Davidson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2017.01.024_bb0045","first-page":"5314541","article-title":"Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications","volume":"2016","author":"Dos Passos","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"4","key":"10.1016\/j.jneuroim.2017.01.024_bb0050","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/imm.12334","article-title":"Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis","volume":"143","author":"Ferreira","year":"2014","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.jneuroim.2017.01.024_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaut.2006.02.002","article-title":"Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases","volume":"26","author":"Goules","year":"2006","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.jneuroim.2017.01.024_bb0060","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00415-016-8128-x","article-title":"Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study","volume":"263","author":"Havrdov\u00e1","year":"2016","journal-title":"J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2017.01.024_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2008.03.009","article-title":"Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay","volume":"196","author":"Hayakawa","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.01.024_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2567.2008.02837.x","article-title":"T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis","volume":"125","author":"Hedegaard","year":"2008","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.jneuroim.2017.01.024_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064631","article-title":"Soluble CD40 ligand stimulates CD40-dependent activation of the \u03b22 integrin Mac-1 and protein kinase C zeda (PKC\u03b6) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jneuroim.2017.01.024_bb0080","article-title":"Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS","volume":"2","author":"Kim","year":"2015","journal-title":"Neurol. Neurophysiol. Neurosci."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.01.024_bb0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1567202612666150102124703","article-title":"Platelets in the Alzheimer's disease brain: do they play a role in cerebral amyloid angiopathy?","volume":"12","author":"Kniewallner","year":"2015","journal-title":"Curr. Neurovasc. Res."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.01.024_bb0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.01.024_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135245859900500206","article-title":"Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis","volume":"5","author":"Matusevicius","year":"1999","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.01.024_bb0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"28","key":"10.1016\/j.jneuroim.2017.01.024_bb0105","doi-asserted-by":"crossref","first-page":"9454","DOI":"10.1523\/JNEUROSCI.5796-09.2010","article-title":"Dyad of CD40\/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis","volume":"30","author":"Ramirez","year":"2010","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.01.024_bb0110","first-page":"99","article-title":"Cerebrospinal fluid\u2014physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases","volume":"4","author":"Reiber","year":"1998","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.jneuroim.2017.01.024_bb0115","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaneurol.2015.0533","article-title":"Long-term therapy with interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder","volume":"72","author":"Ringelstein","year":"2015","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.01.024_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tracli.2012.02.003","article-title":"CD40 ligand (CD154) involvement in platelet transfusion reactions","volume":"19","author":"Sahler","year":"2012","journal-title":"Transfus. Clin. Biol."},{"issue":"5","key":"10.1016\/j.jneuroim.2017.01.024_bb0125","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar2833","article-title":"Increased levels of circulating microparticles in primary Sj\u00f6gren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity","volume":"11","author":"Sellam","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2017.01.024_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13075-015-0757-4","article-title":"CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study","volume":"17","author":"Shock","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.jneuroim.2017.01.024_bb0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1191\/0961203304lu1032oa","article-title":"Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients","volume":"13","author":"Sidiropoulos","year":"2004","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.jneuroim.2017.01.024_bb0140","article-title":"Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro","volume":"4","author":"Takeshita","year":"2016","journal-title":"Neurol. Neurophysiol. Neurosci."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.01.024_bb0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2017.01.024_bb0150","article-title":"Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: their possible role on blood-brain barrier disruption","author":"Uchida","year":"2016","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.jneuroim.2017.01.024_bb0155","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","article-title":"Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis","volume":"256","author":"Uzawa","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2017.01.024_bb0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2013.03.020","article-title":"Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks","volume":"421","author":"Uzawa","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.jneuroim.2017.01.024_bb0165","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J","article-title":"Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera","volume":"42","author":"Vakkalanka","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.01.024_bb0170","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol. Neurophysiol. Neurosci."},{"issue":"10","key":"10.1016\/j.jneuroim.2017.01.024_bb0175","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jneuroim.2017.01.024_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2017.01.024_bb0185","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol. Neurophysiol. Neurosci."},{"issue":"6","key":"10.1016\/j.jneuroim.2017.01.024_bb0190","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00401-015-1501-5","article-title":"Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS","volume":"130","author":"Zeka","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2017.01.024_bb0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2016.08.015","article-title":"Serum concentration of CD40L is elevated in inflammatory demyelinating diseases","volume":"299","author":"Zhong","year":"2016","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816304714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816304714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:26Z","timestamp":1759048166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816304714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":39,"alternative-id":["S0165572816304714"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.01.024","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble CD40 ligand contributes to blood\u2013brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}